Full Text
EE372 Cost-Effectiveness Analysis of Lenvatinib vs Key Comparators in First-Line Unresectable Hepatocellular Carcinoma in Canada

Abstract

Authors

Kerigo Ndirangu Shivani Kamdar Alice Li Mark Pennington Jack Scerri David Trueman

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×